Geode Capital Management, LLC Sight Sciences, Inc. Transaction History

Geode Capital Management, LLC

$1.07 Trillion
Q1 2024

A detailed history of Geode Capital Management, LLC transactions in Sight Sciences, Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 581,371 shares of SGHT stock, worth $3.58 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

581,371

Previous 565,091 2.88%

Holding current value

$3.58 Million

Previous $2.92 Million 5.28%

% of portfolio

0.0%

Previous 0.0%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$4.02 - $5.89 $65,445 - $95,889	16,280 Added 2.88%	581,371 $3.07 Million
Q4 2023 Feb 13, 2024	BUY	$1.29 - $5.86 $44,882 - $203,886	34,793 Added 6.56%	565,091 $2.92 Million
Q3 2023 Nov 13, 2023	BUY	$2.88 - $8.8 $125,579 - $383,715	43,604 Added 8.96%	530,298 $1.79 Million
Q2 2023 Aug 11, 2023	BUY	$7.46 - $10.67 $51,444 - $73,580	6,896 Added 1.44%	486,694 $4.03 Million
Q1 2023 May 15, 2023	BUY	$8.44 - $13.35 $105,702 - $167,195	12,524 Added 2.68%	479,798 $4.19 Million

Q4 2022 Feb 13, 2023	BUY	$5.58 - $13.94 $53,501 - $133,656	9,588 Added 2.09%	467,274 $5.71 Million
Q3 2022 Nov 14, 2022	BUY	$6.1 - $11.41 $843,837 - $1.58 Million	138,334 Added 43.32%	457,686 $2.91 Million
Q2 2022 Aug 12, 2022	BUY	$6.61 - $11.99 $89,472 - $162,296	13,536 Added 4.43%	319,352 $2.87 Million
Q1 2022 May 13, 2022	BUY	$11.56 - $17.9 $1.3 Million - $2.02 Million	112,794 Added 58.44%	305,816 $3.54 Million
Q4 2021 Feb 11, 2022	BUY	$17.36 - $27.36 $222,138 - $350,098	12,796 Added 7.1%	193,022 $3.39 Million
Q3 2021 Nov 12, 2021	BUY	$22.34 - $39.1 $4.03 Million - $7.05 Million	180,226 New	180,226 $4.09 Million

Others Institutions Holding SGHT

# of Institutions

Shares Held

21.1M

Call Options Held

33.2K

Put Options Held

27.7K

View Full List

About Sight Sciences, Inc.

Ticker SGHT
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 47,826,200
Market Cap $295M
Description
Sight Sciences, Inc., an ophthalmic medical device company, engages in the development and commercialization of surgical and nonsurgical technologies for the treatment of eye diseases. The company's products include OMNI Surgical System, a therapeutic device used by ophthalmic surgeons to reduce intraocular pressure in adult glaucoma patients; a...

More about SGHT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.

Account

Geode Capital Management, LLC Sight Sciences, Inc. Transaction History